Osteoarthritis (OA) is the most common form of arthritis in adults, which is characterised by persistent pain, loss of mobility and reduced quality of life. In the UK alone, there are an estimated 5.4 million people living with knee OA and 3.2 million people with hip OA. As the population ages, coupled with rising obesity…

Patients in the NHS may manage OA symptoms in the early stages conservatively with analgesic medication, steroid injections, exercise, physiotherapy and weight reduction. There is an imperative to reduce opioid use for persistent pain, due to addiction risk, side effects and long-term increased sensitivity to pain. There is growing evidence to refute the usefulness of…

In 2016 IBSA recognised the limitation of linear and cross-linked technology in producing HA. Their scientists researched and created a patented technology to produce a novel molecular structure for HA consisting of a hybrid cooperative complex, combining both high and low molecular weight in a single injection (Sinovial HL®), signifying an innovative step forward in…